inhibitors - inhibitors Manufacturer Supplier Exporter

Price

Supplier Type

Manufacturer
custom synthesis
Trader
Reagent
contract manufacturer

Supplier Region

Hyderabad(10)
Gujarat(15)
Mumbai(19)
Telangana(2)
Maharashtra(19)
Bangalore(1)
Ahmedabad(5)
Nagpur(1)
Haryana(2)
Delhi(2)
Uttar Pradesh(3)
Vadodara(2)
Pune(1)
Tamil Nadu(2)
Karnataka(2)
Beijing(1)
New Delhi(2)
Andhra Pradesh(2)

Purity

Z-VAD-FMK, CAS 187389-52-2, is a cell-permeable, irreversible, pan-caspase inhibitor.
VETRANAL?, analytical standard
United States Pharmacopeia (USP) Reference Standard
The AhR Antagonist, also referenced under CAS 301326-22-7, controls the biological activity of AhR.
synthetic, ≥90% (HPLC)
solid, ≥98% (HPLC)
Single-chain glycoprotein present in normal serum at about 23 mg/100 ml.
reference standard
recombinant
puriss. p.a., absolute, ≥99.5% (GC)
powder, ≥98% (HPLC)
powder
pharmaceutical secondary standard, certified reference material
Pharmaceutical Secondary Standard
Min. 99%
lyophilized powder, ≥95% (SDS-PAGE)
LRRK2-IN-1 primarily used in Inhibition.
ISOPAC?
InSolution,≥95%
InSolution, ≥98%, 50 mM in DMSO, A cell-permeable benzodiazepine compound
InSolution, ≥98%, 10 mM, reversible and specific inhibitor of PI 3-kinase
InSolution, ≥98%, 1 mg/ml, reversible inhibitor of p38 MAP kinase
InSolution, ≥97%, 25 mM in DMSO
InSolution, ≥97%
InSolution, ≥95%, protein kinase C (PKC) inhibitor
InSolution, ≥95%, Inhibitor of protein kinase C
InSolution, ≥95%, inhibitor of cyclin-dependent kinases (CDKs)
InSolution, ≥95%
IC?? = 800 nM).
Hesperadin primarily used in Inhibition.
HCl 98%
Greater than 99%
European Pharmacopoeia (EP) Reference Standard
CRS, European Pharmacopoeia (EP) Reference Standard
Certified Reference Material
bulk package
British Pharmacopoeia (BP) Reference Standard
BioReagent, suitable for fluorescence, ≥96.0% (HPLC)
Batimastat primarily used in Inhibition.
analytical standard
AldrichCPR
A widely used anti-neoplastic agent that also displays immunosuppressant properties.
A potent, cell-permeable, reversible, and selective inhibitor of cyclin-dependent kinases.
A potent inhibitor of HDACs and receptor tyrosine kinases
A natural metabolite of 17β-estradiol that is devoid of estrogenic activity.
A cell-permeable, selective inhibitor of cAMP-specific phosphodiesterase (PDE IV
A cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality.
99.94%
99.9%
99.66%
99.5%
≥99.5%
99.10%
≥99.0% (NT)
99%+
≥99%, crystalline
99% purity
99% (HPLC Tested)
>99%
99%
98+
98.50%
98.42%
98.32%
98.0-102.0%, solid
98.00%
>98.0%(T)(HPLC)
>98.0%(T)
>98.0%(N)
>98.0%(HPLC)(N)
>98.0%(HPLC)
>98.0%(GC)
≥98% (TLC)
≥98% (HPLC), white to off-white, powder
>98% (HPLC), solid
≥98% (HPLC), solid
≥98% (HPLC), powder
≥98% (HPLC)
>98% (HPLC)
98%
98 %
97-99%
>97.0%(N)
>97.0%(HPLC)(N)
>97.0%(HPLC)
>97.0%(GC)
≥97% (HPLC), solid
≥97% (HPLC)
97%
95.00%
>95.0%(T)(HPLC)
>95.0%(HPLC)
≥95%, powder
≥95% (HPLC), powder
≥95% (HPLC)
>95% (HPLC)
90070559
>90.0%(HPLC)
90 % Above
100%
1.0?mg/mL in methanol, ampule of 1?mL, certified reference material, Cerilliant?
1.0?mg/mL in methanol (as free base), ampule of 1?mL, certified reference material, Cerilliant?
&ge